Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
11/2014
11/04/2014US8877757 Pyrazine derivatives and use as PI3K inhibitors
10/2014
10/30/2014US20140323703 Dark quenchers for donor-acceptor energy transfer
10/30/2014US20140323484 Pharmaceutically Active Pyrazine Derivatives
10/30/2014US20140323467 Therapeutic compounds and compositions
10/30/2014US20140323463 Pyrazinecarboxamide compound
10/28/2014US8871976 Chalcone structure fluorescence dye for embryonic stem cell probe
10/28/2014US8871932 Process for the preparation of tadalafil
10/28/2014US8871931 Di-O-methylcoelenteramide and analogs thereof for production of coelenteramide and analogs thereof
10/28/2014US8871772 Therapeutic methods and compounds
10/23/2014US20140316137 Coelenterazine analogues and coelenteramide analogues
10/23/2014US20140316118 Dark quenchers for donor-acceptor energy transfer
10/23/2014US20140315922 Method of treating parkinson's disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity
10/23/2014US20140315913 Substituted pyridine and pyrazine compounds as pde4 inhibitors
10/23/2014US20140315898 N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
10/21/2014US8865732 Heterocyclic compounds and uses thereof
10/21/2014US8865721 Delta opioid receptor agonist compounds
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309192 Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
10/14/2014US8859768 Heteroaryls and uses thereof
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859559 Substituted pyrazines and their use in the treatment of disease
10/14/2014US8859558 Pyrazinyl carboxamides as fungicides
10/14/2014US8859555 Lysine Specific Demethylase-1 inhibitors and their use
10/14/2014US8859111 Materials for organic electroluminescent devices
10/14/2014US8858828 Use of 2-(3-aminopropoxy)ethan-1-ol as an absorbent to remove acidic gases
10/09/2014US20140303172 Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Lymphoproliferative Malignancies
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2785700A1 Anticoagulant reversal agents
10/07/2014USRE45183 Heteroaryl-ureas and their use as glucokinase activators
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
10/02/2014US20140296225 Inhibitors of the Renal Outer Medullary Potassium Channel
09/2014
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846687 Pyrazine compounds as PI3 kinase inhibitors
09/25/2014WO2014152663A1 Crystalline forms of tyrosine kinase inhibitors and their salts
09/25/2014WO2014151616A1 Biaryl amide compounds as kinase inhibitors
09/25/2014WO2014146752A1 Materials for electronic devices
09/25/2014WO2014146494A1 Β-aminocarbonyl compound, preparation method, pharmaceutical composition and use thereof
09/25/2014US20140288304 Formation of n-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-n-protected amino ester
09/25/2014US20140288086 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
09/25/2014US20140288077 Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity
09/25/2014US20140288059 Therapeutic compositions and methods
09/24/2014EP2780331A1 Pharmaceutically active pyrazine derivatives
09/23/2014US8841309 Substituted pyrazines and their use in the treatment of disease
09/23/2014CA2596393C 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
09/18/2014WO2014145119A1 Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
09/18/2014WO2014144895A1 Microcrystalline diketopiperazine compositions and methods
09/18/2014WO2014144003A1 Formation of n-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-n-protected amino ester
09/18/2014WO2014140059A1 ARYL SULFAMIDE AND SULFAMATE DERIVATIVES AS RORc MODULATORS
09/18/2014US20140275543 Stabilized compositions and methods of manufacture
09/18/2014US20140275093 Substituted hydroxamic acids and uses thereof
09/18/2014US20140275059 Dna-pk inhibitors
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275008 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140271888 Diketopiperazine microparticles with defined specific surface areas
09/17/2014EP2776408A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
09/17/2014EP2776407A1 Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
09/16/2014US8835636 Method for producing dichloropyrazine derivative
09/16/2014US8835634 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
09/16/2014US8835491 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
09/16/2014US8835467 SIR2 regulation
09/16/2014US8835419 Substituted anilines as CCR(4) antagonists
09/12/2014WO2014135730A1 Haptenes and conjugates derived from pyocyanin, antibodies thereof, and immunochemical method for detecting infections caused by pseudomonas aeruginosa
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256549 Labile esters of agrochemicals for controlled release and reduction of off-site movement
09/10/2014EP2773624A1 Novel process for the preparation of acylguanidines and acylthioureas
09/10/2014EP2773622A1 Pesticidal compounds
09/10/2014EP2773615A1 Pharmaceutical compounds
09/04/2014US20140249135 Pim kinase inhibitors and methods of their use
09/03/2014EP2771327A1 Novel pyrazine derivatives
09/03/2014EP2771319A1 Amino acid derivatives functionalized on the n- terminal capable of forming drug incapsulating microspheres
09/03/2014EP2771005A1 Inhibitors of the renal outer medullary potassium channel
09/03/2014EP2771004A1 Inhibitors of the renal outer medullary potassium channel
09/02/2014US8822679 Quaternary heteroatom containing compounds
09/02/2014US8822472 Piperazines, pharmaceutical compositions and methods of use thereof
09/02/2014US8822469 Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
09/02/2014US8822467 Biaryl oxyacetic acid compounds
08/2014
08/28/2014US20140243530 Catalysis of Diketopiperazine Synthesis
08/28/2014US20140243345 Selective hdac3 inhibitors
08/27/2014EP2768824A2 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
08/27/2014EP2768809A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
08/26/2014US8816079 Amide derivative and use thereof as medicine
08/26/2014US8816078 Acidic gas removal by aqueous amine solvents
08/26/2014US8815905 Propionic acids, propionic acid esters, and related compounds
08/26/2014US8815862 Co-crystal intermediates of rosuvastatin and methods of using same
08/26/2014US8815859 Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof
08/26/2014US8815852 Carbamoyloxy arylalkan arylpiperazine analgesics
08/26/2014US8815842 Anti-foot-and-mouth disease virus agent for animal belonging to family Suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family Suidae or sheep
08/26/2014CA2653039C Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
08/21/2014WO2014125075A1 Albicidin derivatives, their use and synthesis
08/21/2014US20140235650 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
08/21/2014US20140235636 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
08/21/2014US20140235579 Heterocyclic compounds for the inhibition of pask
08/19/2014US8809427 Phthalocyanine compound and production method therefor, and coloring composition containing the phthalocyanine compound
08/19/2014US8809340 Crystalline form
08/19/2014US8809339 Compounds and methods for inhibiting phosphate transport
08/14/2014WO2014121885A1 Substituted quinoxaline derivatives and their use as positive allosteric modulators of mglur4
08/14/2014WO2014121884A1 Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 187